carbazilquinone has been researched along with Remission, Spontaneous in 1 studies
Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, T | 1 |
| Nemoto, R | 1 |
| Nishimoto, T | 1 |
| Kumagai, I | 1 |
| Miura, K | 1 |
1 other study available for carbazilquinone and Remission, Spontaneous
| Article | Year |
|---|---|
Chemosensitivity of human bladder cancer cells in long-term culture and clinical responses to the selected anticancer drug.
Topics: Antineoplastic Agents; Azirines; Carbazilquinone; Carcinoma, Transitional Cell; Cell Line; Cell Surv | 1979 |